- Filed
- May 14, 2026 12:00 AM ET
- Period of report
- —
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | Q1 2026 · May 11, 2026 | 28M sh |
| Shares Diluted | Q1 2026 · Mar 31, 2026 | 28.67M sh |
| Shares Diluted | Q1 2026 · Mar 31, 2025 | 15.02M sh |
| Operating Cash Flow | Q1 2026 · Mar 31, 2026 | −$14.55M |
| Operating Cash Flow | Q1 2026 · Mar 31, 2025 | −$22.84M |
| Cash And Equivalents | Q1 2026 · Mar 31, 2026 | $14.14M |
| Cash And Equivalents | Q1 2026 · Dec 31, 2025 | $28.69M |
| Stockholders Equity | Q1 2026 · Mar 31, 2026 | $3.4M |
| Stockholders Equity | Q1 2026 · Dec 31, 2025 | $4.15M |
| Stockholders Equity | Q1 2026 · Mar 31, 2025 | $42.24M |
| Stockholders Equity | Q1 2026 · Dec 31, 2024 | $61.67M |
| Current Liabilities | Q1 2026 · Mar 31, 2026 | $9M |
| Current Liabilities | Q1 2026 · Dec 31, 2025 | $13.2M |
| Total Liabilities | Q1 2026 · Mar 31, 2026 | $17.78M |
| Total Liabilities | Q1 2026 · Dec 31, 2025 | $31.63M |
| Current Assets | Q1 2026 · Mar 31, 2026 | $20.29M |
| Current Assets | Q1 2026 · Dec 31, 2025 | $34.65M |
| Total Assets | Q1 2026 · Mar 31, 2026 | $21.18M |
| Total Assets | Q1 2026 · Dec 31, 2025 | $35.78M |
| Eps Diluted | Q1 2026 · Mar 31, 2026 | −$0.04 |
| Eps Diluted | Q1 2026 · Mar 31, 2025 | −$1.41 |
| Eps Basic | Q1 2026 · Mar 31, 2026 | −$0.04 |
| Eps Basic | Q1 2026 · Mar 31, 2025 | −$1.41 |
| Sga Expense | Q1 2026 · Mar 31, 2026 | $5.14M |
| Sga Expense | Q1 2026 · Mar 31, 2025 | $5.65M |
| Rd Expense | Q1 2026 · Mar 31, 2026 | $5.81M |
| Rd Expense | Q1 2026 · Mar 31, 2025 | $16.16M |
| Net Income | Q1 2026 · Mar 31, 2026 | −$1.17M |
| Net Income | Q1 2026 · Mar 31, 2025 | −$21.24M |
| Operating Income | Q1 2026 · Mar 31, 2026 | −$10.95M |
| Operating Income | Q1 2026 · Mar 31, 2025 | −$21.8M |
| Cost Of Revenue | Q1 2026 · Mar 31, 2026 | $3.62M |
| Cost Of Revenue | Q1 2026 · Mar 31, 2025 | $9.76M |